Financials

v3.6.0.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Dec. 31, 2016
Sep. 30, 2016
Current assets:    
Cash and cash equivalents $ 1,895 $ 3,155
Accounts receivable 544 750
Prepaid expenses and other current assets 178 230
Total current assets 2,617 4,135
Investment in CPEC LLC 32 32
Total assets 2,649 4,167
Current liabilities:    
Accounts payable and accrued expenses 514 972
Total current liabilities 514 972
Total liabilities 514 972
Stockholders' (deficit) equity:    
Common stock, $.01 par value per share, 200,000,000 shares authorized; 152,085,825 shares issued and outstanding as of December 31, 2016 and September 30, 2016, respectively 1,520 1,520
Additional paid-in capital 191,890 191,863
Accumulated deficit (191,275) (190,188)
Total stockholders' equity 2,135 3,195
Total liabilities and stockholders' equity 2,649 4,167
Series A nonredeemable convertible preferred stock    
Stockholders' (deficit) equity:    
Preferred stock, $.01 par value per share, 10,000,000 shares authorized: 0 0
Series B nonredeemable convertible preferred stock    
Stockholders' (deficit) equity:    
Preferred stock, $.01 par value per share, 10,000,000 shares authorized: 0 0
Series C nonredeemable convertible preferred stock    
Stockholders' (deficit) equity:    
Preferred stock, $.01 par value per share, 10,000,000 shares authorized: $ 0 $ 0
v3.6.0.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Revenue:    
Contract revenue $ 83 $ 305
Costs and expenses:    
Research and development 489 492
General and administrative 681 561
Total costs and expenses 1,170 1,053
Loss from operations (1,087) (748)
Interest expense 0 285
Net loss (1,087) (1,033)
Deemed dividend on Series C preferred stock 0 580
Net loss attributable to common stockholders $ (1,087) $ (1,613)
Net loss per weighted share attributable to common stockholders:    
Basic net loss per common share $ (0.01) $ (0.01)
Diluted net loss per common share $ (0.01) $ (0.01)
Weighted average common shares outstanding:    
Basic 152,086 139,439
Diluted 152,086 139,439
v3.6.0.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities:    
Net loss $ (1,087) $ (1,033)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of discount on note payable to shareholders 0 273
Accrued interest 0 12
Non-cash compensation 27 38
Change in assets and liabilities:    
Accounts receivable 206 714
Deferred subcontractor cost 0 21
Prepaid expenses and other current assets 52 (21)
Accounts payable and accrued expenses (458) (802)
Deferred revenue 0 (22)
Net cash used in operating activities (1,260) (820)
Cash flows from financing activities:    
Proceeds from issuance of common stock and common stock warrants, net 0 2,005
Proceeds from issuance of preferred stock and common stock warrants, net 0 4,165
Net cash provided by financing activities 0 6,170
Net (decrease) increase in cash and cash equivalents (1,260) 5,350
Cash and cash equivalents at beginning of period 3,155 94
Cash and cash equivalents at end of period 1,895 5,444
Supplemental disclosure of non-cash financing activities:    
Conversion of note payable to shareholders for common stock and warrants 0 1,000
Conversion of accrued interest on note payable to shareholders for common stock and warrants 0 12
Issuance of warrants for financing costs 0 266
Deemed dividend on Series C preferred stock $ 0 $ 580